Latigo Biotherapeutics Inc.
Support and Resistance Levels
Past performance
News About LTGO
All events for LTGO
All deals for LTGO
Financial Ratios
Financial Statements
LTGO vs Sector & Peers
About Latigo Biotherapeutics Inc.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA. Website latigobio.com
Headquarters Thousand Oak, CA, US